Literature DB >> 20180053

Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method.

Mrunalini Narkar1, Praveen Sher, Atmaram Pawar.   

Abstract

The purpose of the present work was the development and evaluation of stomach-specific controlled release mucoadhesive drug delivery system prepared by ionotropic gelation of gellan beads, containing acid-soluble drug amoxicillin trihydrate, using 3(2) factorial design with concentration of gellan gum and quantity of drug as variables. The study showed that beads prepared in alkaline cross-linking medium have higher entrapment efficiency than the acidic cross-linking medium. The entrapment efficiency was in the range of 32% to 46% w/w in acidic medium, which increased up to 60% to 90% w/w in alkaline medium. Batches with lowest, medium, and highest drug entrapment were subjected to chitosan coating to form a polyelectrolyte complex film. As polymer concentration increases, entrapment efficiency and particle size increases. Scanning electron microscopy revealed spherical but rough surface due to leaching of drug in acidic cross-linking solution, dense spherical structure in alkaline cross-linking solution, and rough surface of chitosan-coated beads with minor wrinkles. The in vitro drug release up to 7 h in a controlled manner following the Peppas model (r = 0.9998). In vitro and in vivo mucoadhesivity study showed that beads have good mucoadhesivity and more than 85% beads remained adhered to stomach mucosa of albino rat even after 7 h. In vitro growth inhibition study showed complete eradication of Helicobacter pylori. These results indicate that stomach-specific controlled release mucoadhesive system of amoxicillin gellan beads may be useful in H. pylori treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180053      PMCID: PMC2850487          DOI: 10.1208/s12249-010-9384-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa.

Authors:  M Cuña; M J Alonso; D Torres
Journal:  Eur J Pharm Biopharm       Date:  2001-05       Impact factor: 5.571

2.  Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method.

Authors:  H Hägerström; M Paulsson; K Edsman
Journal:  Eur J Pharm Sci       Date:  2000-01       Impact factor: 4.384

3.  Effect of core and surface cross-linking on the entrapment of metronidazole in pectin beads.

Authors:  Atmaram P Pawar; Anil R Gadhe; Prabakaran Venkatachalam; Praveen Sher; Kakasaheb R Mahadik
Journal:  Acta Pharm       Date:  2008-03       Impact factor: 2.230

4.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

Review 6.  Chitosan--as a biomaterial.

Authors:  T Chandy; C P Sharma
Journal:  Biomater Artif Cells Artif Organs       Date:  1990

7.  Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure.

Authors:  X Z Shu; K J Zhu
Journal:  Int J Pharm       Date:  2002-02-21       Impact factor: 5.875

8.  Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells.

Authors:  F Megraud; H Lamouliatte; L Boyanova
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

9.  Glucosamine oligomers: 4. Solid state-crystallization and sustained dissolution.

Authors:  A Domard; N Cartier
Journal:  Int J Biol Macromol       Date:  1992-04       Impact factor: 6.953

10.  Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori.

Authors:  N Nagahara; Y Akiyama; M Nakao; M Tada; M Kitano; Y Ogawa
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more
  8 in total

1.  Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion.

Authors:  Saahil Arora; R D Budhiraja
Journal:  J Adv Pharm Technol Res       Date:  2012-01

2.  Formulation and In Vitro evaluation of pH sensitive oil entrapped polymeric blended gellan gum buoyant beads of clarithromycin.

Authors:  G Tripathi; S Singh
Journal:  Daru       Date:  2010       Impact factor: 3.117

3.  Formulation and In-vitro Evaluation of pH-Sensitive Oil Entrapped Polymeric Blend Amoxicillin Beads for the Eradication of Helicobacter pylori.

Authors:  Girish Kumar Tripathi; Satyawan Singh; Gopal Nath
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

4.  Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and in vitro evaluation.

Authors:  Zaheer Abbas; Sachin Marihal
Journal:  J Pharm Bioallied Sci       Date:  2014-10

5.  Highly tailorable gellan gum nanoparticles as a platform for the development of T cell activator systems.

Authors:  Daniel B Rodrigues; Helena R Moreira; Mariana T Cerqueira; Alexandra P Marques; António G Castro; Rui L Reis; Rogério P Pirraco
Journal:  Biomater Res       Date:  2022-09-30

6.  Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres.

Authors:  Sree Harsha
Journal:  Int J Nanomedicine       Date:  2012-09-04

7.  Pharmaceutical suspension containing both immediate/sustained-release amoxicillin-loaded gelatin nanoparticles: preparation and in vitro characterization.

Authors:  Sree Harsha
Journal:  Drug Des Devel Ther       Date:  2013-09-26       Impact factor: 4.162

8.  Docetaxel-Loaded Disulfide Cross-Linked Nanoparticles Derived from Thiolated Sodium Alginate for Colon Cancer Drug Delivery.

Authors:  Hock Ing Chiu; Asila Dinie Ayub; Siti Nur Aishah Mat Yusuf; Noorfatimah Yahaya; Erazuliana Abbd Kadir; Vuanghao Lim
Journal:  Pharmaceutics       Date:  2020-01-02       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.